SCHEMBL28639721

SCHEMBL28639721

COCOc1cc(OCOC)c(C(=O)C=Cc2ccc(OC)c(OCc3ccccc3)c2)c(OCOC)c1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 1/20 0.67
▸ PDE4B Q07343 1/20 0.67
▸ PDE4C Q08493 1/20 0.67
▸ PDE4D Q08499 1/20 0.67
▸ APP P05067 6/20 0.56
▸ GSK3B P49841 1/20 0.55
▸ KDM4E B2RXH2 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ HPGD P15428 2/20 0.53
▸ HTT P42858 1/20 0.53
▸ MMP1 P03956 3/20 0.52
▸ MMP2 P08253 2/20 0.52
▸ MMP3 P08254 2/20 0.52
▸ MMP9 P14780 2/20 0.52
▸ MMP12 P39900 2/20 0.52
▸ MMP13 P45452 2/20 0.52
▸ ABCG2 Q9UNQ0 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10609463 0.98 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL10612814 0.98 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL28647651 0.95 PDE4A (0.64) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL10610437 0.93 PDE4A (0.74) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL10610432 0.93 PDE4A (0.74) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL25196754 0.91 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL30383937 0.91 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL30383214 0.91 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL25196269 0.91 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DAPP
SCHEMBL25191013 0.90 PDE4A (0.65) PDE4APDE4BPDE4CPDE4DAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110294732-B Pharmaceutical compound for treating liver diseases and application thereof 江苏新元素医药科技有限公司 2021-10-26 — — CN disclosed
Send feedback